Innovation and Product Development news (page 5)

• 

  8 June 2026

  Roche and Nurix partner to co-develop and co-commercialise BTK degrader bexobrutideg

  Collaboration targets B‑cell malignancies, immunology and neurology with an oral, brain‑penetrant BTK degrader planned for Phase 3 in summer 2026.
• 

  8 June 2026

  AGC Biologics to develop and manufacture KTP-001 (rhMMP-7) for Teikoku Pharma

  Microbial process development and GMP clinical manufacturing of rhMMP‑7 for intradiscal injection; cell bank moved from Heidelberg to Chiba; intended as a lumbar disc herniation treatment.
• 

  7 June 2026

  Boehringer Ingelheim: Survodutide Phase III shows up to 34% visceral and 63% liver fat reduction with limited lean mass loss

  Phase III data show targeted visceral and liver fat reductions with minimal lean mass loss and sustained weight loss in obesity and MASLD populations.
• 

  7 June 2026

  Novo Nordisk CagriSema Phase 3 trials show large HbA1c and weight reductions

  Once‑weekly cagrilintide+semaglutide reduced HbA1c by up to 2.33 percentage points and bodyweight by up to 14.2% across REIMAGINE 1–3 versus comparators.
• 

  7 June 2026

  Lilly Foundayo shows weight loss across pre-, peri- and post‑menopause

  Orforglipron produced meaningful body‑weight and waist reductions across menopausal stages in ATTAIN‑1 and ATTAIN‑2, including women with type 2 diabetes.
• 

  7 June 2026

  Amgen: Repatha (evolocumab) cuts first major CV events 29% in high‑risk diabetes subgroup

  VESALIUS‑CV subgroup shows evolocumab lowers first major cardiovascular events and LDL‑C; real‑world GLP‑1 persistence is low, curbing potential benefits.

• 

  6 June 2026

  Lilly's retatrutide shows major weight loss and benefits for diabetes, knee osteoarthritis and OSA

  Triple agonist produced up to 28.3% weight loss at 80 weeks, A1C fell up to 2.0% at 40 weeks, with large reductions in knee pain and sleep apnea severity.
• 

  6 June 2026

  Novo Nordisk: semaglutide 2 mg escalation matches tirzepatide for HbA1c <7% and yields greater ≥5% weight loss

  Real‑world claims analysis found semaglutide 2 mg escalation gave similar HbA1c <7% rates and higher ≥5% weight‑loss rates than switching to titratable tirzepatide.
• 

  6 June 2026

  Novo Nordisk: semaglutide (Wegovy) post‑hoc data across cardiometabolic conditions

  Post‑hoc analyses link semaglutide to lower OSA incidence, fewer asthma events, improved systolic BP, and liver and cardiometabolic improvements across SELECT, STEP, ESSENCE and OASIS trials.
• 

  5 June 2026

  Röhm opens Bay City MMA plant as LiMA technology reaches full industrial scale

  Proprietary LiMA process reaches full industrial scale; Bay City becomes North America’s first C2‑based MMA site with 250,000 tpa capacity and enhanced sustainability measures.
• 

  5 June 2026

  Novo Nordisk zenagamtide (amycretin) delivers large HbA1c and weight reductions in phase 2 T2D trial

  Unimolecular GLP‑1/amylin agonist produced substantial HbA1c and weight reductions in a 36‑week phase 2 trial in adults with type 2 diabetes on metformin ± SGLT2i.
• 

  5 June 2026

  Clariant launches Exolit AP 422 A — SVHC‑free ammonium polyphosphate

  New non‑halogenated APP for intumescent coatings, firestop seals and PIR insulation; contains <0.1% melamine to meet REACH SVHC criteria.
• 

  5 June 2026

  Clariant expands Daya Bay capacity and extends Exolit™ OP range for e-mobility

  CHF 100 million Daya Bay expansion with second line operational in November; new halogen-free PBT Exolit OP grades for 800V+ e-mobility; ATO-free options and AP 422 A (melamine <0.1%).
• 

  5 June 2026

  AGC wins Syngenta Supplier Award for Waste Reduction

  Awarded for a process change that recycles a reaction by‑product, cutting waste to near zero, lowering CO₂ by over 1,000 tons/year and reducing production costs.
• 

  4 June 2026

  Toray to build TORELINA PPS resin plant in India

  New Suri City line will add about 3,000 t/y of PPS compound capacity, start operations early 2027 with customer samples in April 2027, targeting automotive and electrical components.
• 

  4 June 2026

  PPG, IPG Photonics and Whirlpool win 2026 IRI Open Innovation Award for laser curing

  Developed a laser curing platform to replace thermal ovens in powder coating lines, cutting energy use and increasing line speed while working with conventional and laser‑activated powders.
• 

  4 June 2026

  BASF launches InVigor Gold L322 canola hybrid for 2027 (Montana)

  Early‑maturing Brassica juncea hybrid for warmer, drier, low‑organic soils; offers native pod‑shatter tolerance and LibertyLink weed control; availability in Montana pending approvals.
• 

  4 June 2026

  LyondellBasell wins Toyota Motor Europe award for polymers from fishing nets

  Recognition for developing postconsumer recycled polymers from maritime-recovered fishing nets for automotive use, validated through two years of testing and evaluation.
• 

  4 June 2026

  Caleyda: food‑grade approval process begins

  EFRO-funded plesTic Ready backs an exploration of food-grade certification for mixed-culture PHA from organic residual streams with value‑chain partners.
• 

  4 June 2026

  Avantium and MEP Baljeu host EU dialogue on reindustrialising through sustainable chemistry

  Parliament event on 24 June 2026 will examine whether bio‑based and circular carbon can underpin European chemical competitiveness and cut fossil feedstock reliance.
• 

  4 June 2026

  PETRONAS MoU with regional partners to advance offshore IOR/EOR

  Regional E&P operators and UTP will jointly evaluate fit‑for‑purpose IOR/EOR studies for offshore fields, supported by laboratory testing and potential pilot projects.
• 

  4 June 2026

  Sumitomo Corporation takes 49% stake in Graphyte-led US JV for CDR credits

  49% stake in US JV to commercialise 'Carbon Casting' BiCRS, scale the Loblolly project to 50,000 tCO2/yr, and sell long-duration CDR credits across North America and Japan.
• 

  3 June 2026

  Air Liquide invests in Quobly to scale silicon quantum processors

  Investment funds R&D and industrialisation of silicon-based quantum processors, backing commercial launch targeted by end‑2026.
• 

  3 June 2026

  BASF appoints Steve Arndt Senior VP, Global Automotive Refinish Coatings

  Arndt succeeds Titmarsh as global head of automotive refinish coatings on 1 July 2026; Titmarsh steps down after a 20-year company career.
• 

  3 June 2026

  Siemens and HighByte: HighByte Intelligence Hub added to Industrial Edge

  Native Industrial Edge app to unify OT and IT data, contextualize and pipeline datasets for AI model training and secure setpoint control via Intelligence Center X.
• 

  3 June 2026

  BASF Intermediates Geismar Acetylene Unit wins ACC Energy Efficiency Award

  Geismar unit cut energy use by deploying advanced process control (APC), earning the ACC's Responsible Care 2026 Energy Efficiency Award.
• 

  3 June 2026

  Johnson & Johnson: nipocalimab lowers SLE disease activity in Phase 2 JASMINE study

  Phase 2 data show FcRn blocker nipocalimab reduced SLE activity versus placebo, with larger benefit in autoantibody‑positive patients and no new safety signals.
• 

  3 June 2026

  MAIRE awarded Industry Mover in S&P Global Sustainability Yearbook 2026

  Recognised for the largest year-on-year ESG improvement in its sector; 2025 gains include a 6% cut to Scope 1–2 emissions, 1.2 Mt CO2 avoided and 90,000 m³ of water reused.
• 

  3 June 2026

  Borouge International & Lanxess advance circular acetone with Borvida B‑acetone

  ISCC PLUS‑certified, mass‑balanced acetone from non‑food waste biomass offers up to 175% cradle‑to‑gate carbon reduction while matching conventional acetone performance.
• 

  3 June 2026

  UBE MAXELL expands Li-ion separator capacity at Sakai Works

  New Sakai Works facility will boost separator base‑film output ~50% with phase‑one in FY2026 and phase‑two in FY2029; complements a facility due in fall 2026 to serve automotive and ESS demand.